On August 8, the 2026 (20th) China Brand Festival officially kicked off at the Conference Center of Beijing International Hotel, themed “Global Expansion and Ecosystem‑Building”. Marking the 20th anniversary of the China Brand Festival, this grand event gathered 2,000 representatives from government, business, industry, academia and the media. It reviewed the achievements of Chinese brands over the past two decades, targeted the new track of ecosystem‑driven global expansion, and embarked on a new journey toward high‑quality globalization for Chinese brands.

Huang Shan, Partner of China Brand Festival, Director and President of Jinyi Technology Group & Hainan Huayan; Wang Xiaoping, General Manager of Huayan Collagen Brand Division and Deputy General Manager of Huayan Bio‑technology; and Wang Ming, Executive Dean of Huayan Collagen Business School and Deputy General Manager of Huayan Bio‑technology, were invited to attend the festival. At the ceremony, Hainan Huayan was awarded the 2026 China Brand Festival Golden Spectrum Award · Influential Brand in China’s Collagen Peptide Industry. Huang Shan received the TopBrand 2026 China Industry Brand Woman Award and was listed on the 2026 Top 500 Chinese Brand Women. The company’s comprehensive strength and brand‑building achievements have once again received authoritative recognition.

During the forum dialogue, Huang Shan stated, “Looking at the development trajectory of the global health industry, the rise of a nation’s industry always resonates with its overall national strength and supply‑chain capacity. Health consumer goods carry both public‑welfare and industrial attributes. When Chinese brands go global, they export not merely products, but also their supply‑chain systems and quality standards. Therefore, we must shift from relying on single‑sided cost advantages to building full‑chain systematic resilience.” In recent years, Huayan Biotechnology has been deeply exploring featured resources such as bioactive peptides, building a product portfolio embedded with its health‑oriented brand philosophy, entering international markets with differentiated strengths, and delivering Chinese health‑nutrition solutions worldwide.

“From competing on costs and prices in the past to competing on R&D, supply chains and risk‑resistance capabilities today, the global expansion of China’s health industry has entered a brand‑new era. Cutting‑edge technology is our core confidence to compete on the global stage,” Huang Shan remarked. In terms of scientific‑research innovation and supply‑chain development, Hainan Huayan has built an integrated system covering raw‑material R&D, large‑scale production and global traceability. It boasts a professional R&D team and more than 120 authorized patents, and has developed a wide range of proprietary featured functional raw materials.

Backed by its stable, self‑controlled supply‑chain system and continuous technological innovation, Huayan Biotechnology’s products are now exported to over 50 countries and regions including Japan, South Korea, Southeast Asia, the Middle East and the Americas, gradually building global brand awareness. Going forward, the enterprise will continue to strengthen systematic resilience and long‑term competitiveness in its global layout rooted in technology and supported by its supply chain, bringing Chinese biotech health‑solutions to a broader international market.